Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clive Page

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2004
Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine systemZoë Johnson, Marie H Kosco-Vilbois, Suzanne Herren, et al.
Mabs|June 9, 2016
Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 - April 1, 2016, Tours, FranceGuillaume Desoubeaux, Janice M Reichert, Matthew Sleeman, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 14, 2011
Preclinical evaluation of an inhibitor of cytosolic phospholipase A2α for the treatment of asthmaChristopher A Hewson, Sheena Patel, Luigino Calzetta, et al.
British Journal of Clinical Pharmacology|February 2, 2022
Can nebulised HepArin Reduce morTality and time to Extubation in patients with COVID-19 Requiring invasive ventilation Meta-Trial (CHARTER-MT): Protocol and statistical analysis plan for an investigator-initiated international meta-trial of prospective randomised clinical studiesFrank M P van Haren, John G Laffey, Antonio Artigas, et al.
Trials|August 2, 2020
ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trialTom Wilkinson, Rupert Dixon, Clive Page, et al.
ERJ Open Research|October 23, 2023
A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: ACCORD-2Tom Wilkinson, Anthony De Soyza, Miles Carroll, et al.
British Journal of Clinical Pharmacology|January 5, 2022
Inhaled nebulised unfractionated heparin for the treatment of hospitalised patients with COVID-19: A multicentre case series of 98 patientsFrank M P van Haren, Lex M van Loon, Anne Steins, et al.
British Journal of Clinical Pharmacology|December 30, 2020
INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID-19 (INHALE-HEP): Protocol and statistical analysis plan for an investigator-initiated international metatrial of randomised studiesFrank M P van Haren, Alice Richardson, Hwan-Jin Yoon, et al.
Eclinicalmedicine|November 3, 2025
Efficacy of inhaled nebulised unfractionated heparin to prevent intubation or death in hospitalised patients with COVID-19: an investigator-initiated international meta-trial of randomised clinical studiesFrank M P van Haren, Sarah J Valle, Ary Serpa Neto, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2004
Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine systemZoë Johnson, Marie H Kosco-Vilbois, Suzanne Herren, et al.
Mabs|June 9, 2016
Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 - April 1, 2016, Tours, FranceGuillaume Desoubeaux, Janice M Reichert, Matthew Sleeman, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 14, 2011
Preclinical evaluation of an inhibitor of cytosolic phospholipase A2α for the treatment of asthmaChristopher A Hewson, Sheena Patel, Luigino Calzetta, et al.
British Journal of Clinical Pharmacology|February 2, 2022
Can nebulised HepArin Reduce morTality and time to Extubation in patients with COVID-19 Requiring invasive ventilation Meta-Trial (CHARTER-MT): Protocol and statistical analysis plan for an investigator-initiated international meta-trial of prospective randomised clinical studiesFrank M P van Haren, John G Laffey, Antonio Artigas, et al.
Trials|August 2, 2020
ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trialTom Wilkinson, Rupert Dixon, Clive Page, et al.
ERJ Open Research|October 23, 2023
A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: ACCORD-2Tom Wilkinson, Anthony De Soyza, Miles Carroll, et al.
British Journal of Clinical Pharmacology|January 5, 2022
Inhaled nebulised unfractionated heparin for the treatment of hospitalised patients with COVID-19: A multicentre case series of 98 patientsFrank M P van Haren, Lex M van Loon, Anne Steins, et al.
British Journal of Clinical Pharmacology|December 30, 2020
INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID-19 (INHALE-HEP): Protocol and statistical analysis plan for an investigator-initiated international metatrial of randomised studiesFrank M P van Haren, Alice Richardson, Hwan-Jin Yoon, et al.
Eclinicalmedicine|November 3, 2025
Efficacy of inhaled nebulised unfractionated heparin to prevent intubation or death in hospitalised patients with COVID-19: an investigator-initiated international meta-trial of randomised clinical studiesFrank M P van Haren, Sarah J Valle, Ary Serpa Neto, et al.
Pageof 11